BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23720226)

  • 1. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.
    Hofvind S; Ursin G; Tretli S; Sebuødegård S; Møller B
    Cancer; 2013 Sep; 119(17):3106-12. PubMed ID: 23720226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer mortality in Norway after the introduction of mammography screening.
    Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
    Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study.
    Kalager M; Haldorsen T; Bretthauer M; Hoff G; Thoresen SO; Adami HO
    Breast Cancer Res; 2009; 11(4):R44. PubMed ID: 19575807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway.
    Kalager M; Løberg M; Bretthauer M; Adami HO
    Ann Oncol; 2014 Jun; 25(6):1137-43. PubMed ID: 24669012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme.
    Bhargava S; Tsuruda K; Moen K; Bukholm I; Hofvind S
    J Med Screen; 2018 Sep; 25(3):155-161. PubMed ID: 29059006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway.
    Møller MH; Lousdal ML; Kristiansen IS; Støvring H
    Int J Cancer; 2019 Feb; 144(4):697-706. PubMed ID: 30144028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern mammography screening and breast cancer mortality: population study.
    Weedon-Fekjær H; Romundstad PR; Vatten LJ
    BMJ; 2014 Jun; 348():g3701. PubMed ID: 24951459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
    Lund E; Mode N; Waaseth M; Thalabard JC
    BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
    Hofvind S; Lee CI; Elmore JG
    Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing harms and benefits of service mammography screening programs: a cohort study.
    Puliti D; Miccinesi G; Zappa M; Manneschi G; Crocetti E; Paci E
    Breast Cancer Res; 2012 Jan; 14(1):R9. PubMed ID: 22230345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of screening mammography on breast-cancer mortality in Norway.
    Kalager M; Zelen M; Langmark F; Adami HO
    N Engl J Med; 2010 Sep; 363(13):1203-10. PubMed ID: 20860502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.
    Hofvind S; Román M; Sebuødegård S; Falk RS
    J Med Screen; 2016 Dec; 23(4):203-209. PubMed ID: 26940960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M; Adami HO; Bretthauer M; Tamimi RM
    Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.